NEW YORK ( TheStreet) -- CHANGE IN RATINGS Apple ( AAPL) was upgraded at Societe Generale to buy. $575 price target. Company is seeing higher demand, and Android demand could be weakening, Societe Generale said. Archer-Daniels-Midland ( ADM) was upgraded at Bank of America/Merrill Lynch to buy from underperform. New analyst has a $44 price target. Company should benefit from large grain and oilseed crops, BofA/Merrill said. Bunge ( BG) was upgraded at BofA/Merrill to buy from neutral. New analyst has a $90 price target. Company should benefit from large crops in Brazil and the U.S., BofA/Merrill said. Companhia Brasileira De Distribuicao ( CBD) was upgrade to buy at TheStreet Ratings. CBF) was downgraded at Compass Point to neutral from buy. Valuation call, based on a $24 price target, Compass Point said. Chipotle ( CMG) was downgraded at Miller Tabak to hold from buy. Valuation call, based on a fair value of $490 a share, Miller Tabak said. Dean Foods ( DF) was upgraded at BMO Capital to outperform. $23 price target. Adverse operating conditions will likely peak shortly, BMO Capital said. First Horizon ( FHN) was downgraded at RBC Capital to sector perform from outperform. $11 price target. Company is facing a more challenging fundamental outlook, RBC Capital said. Stryker ( SYK) was downgraded to hold at TheStreet Ratings. General Mills ( GIS) was downgraded at BofA/Merrill to neutral from buy. $51 price target. Company is facing lower sales, BofA/Merrill said. GT) was downgraded to hold from buy at Deutsche Bank. $26 price target. Industry has ramped up capital spending, Deutsche Bank said. Kellogg ( K) was downgraded at BofA/Merrill to underperform from buy. $62 price target. Estimates also lowered, given reduced sales expectations, BofA/Merrill said. Kaiser Aluminum ( KALU) was downgraded at Keybanc to hold from buy. Company could be hurt by weaker aerospace plate pricing, Keybanc said. Kaiser Aluminum was downgraded at Sterne Agee to neutral. Company is facing pricing pressure and lacks near-term catalysts, Sterne Agee said. Myriad Genetics ( NOK) downgraded at Credit Suisse to underperform from neutral. $20 price target. Company is facing increased competition, Credit Suisse said. Parker Hannifin ( PH) was upgraded at Robert Baird to outperform from neutral. $122 price target. Company is making progress on the cost side and is seeing better distributor demand, Robert Baird said. Revlon ( REV) was downgraded at BMO Capital to market perform. Valuation call, based on a $31 price target, BMO Capital said.